Matches in Wikidata for { <http://www.wikidata.org/entity/Q56340980> ?p ?o ?g. }
Showing items 1 to 76 of
76
with 100 items per page.
- Q56340980 description "article" @default.
- Q56340980 description "im August 2018 veröffentlichter wissenschaftlicher Artikel" @default.
- Q56340980 description "wetenschappelijk artikel" @default.
- Q56340980 description "наукова стаття, опублікована в серпні 2018" @default.
- Q56340980 description "ലേഖനം" @default.
- Q56340980 name "Tau-Centric Multitarget Approach for Alzheimer's Disease: Development of First-in-Class Dual Glycogen Synthase Kinase 3β and Tau-Aggregation Inhibitors" @default.
- Q56340980 name "Tau-Centric Multitarget Approach for Alzheimer's Disease: Development of First-in-Class Dual Glycogen Synthase Kinase 3β and Tau-Aggregation Inhibitors" @default.
- Q56340980 type Item @default.
- Q56340980 label "Tau-Centric Multitarget Approach for Alzheimer's Disease: Development of First-in-Class Dual Glycogen Synthase Kinase 3β and Tau-Aggregation Inhibitors" @default.
- Q56340980 label "Tau-Centric Multitarget Approach for Alzheimer's Disease: Development of First-in-Class Dual Glycogen Synthase Kinase 3β and Tau-Aggregation Inhibitors" @default.
- Q56340980 prefLabel "Tau-Centric Multitarget Approach for Alzheimer's Disease: Development of First-in-Class Dual Glycogen Synthase Kinase 3β and Tau-Aggregation Inhibitors" @default.
- Q56340980 prefLabel "Tau-Centric Multitarget Approach for Alzheimer's Disease: Development of First-in-Class Dual Glycogen Synthase Kinase 3β and Tau-Aggregation Inhibitors" @default.
- Q56340980 P1433 Q56340980-58F0F0EF-0F60-4664-8236-4132D277DA96 @default.
- Q56340980 P1476 Q56340980-4650609C-D30C-4335-B9CE-44A5A8165A93 @default.
- Q56340980 P2093 Q56340980-059D14F8-A6A4-427A-81EA-03BDDF3E1C05 @default.
- Q56340980 P2093 Q56340980-10D45D5D-52B8-4071-B99F-0EBF44FD1FCC @default.
- Q56340980 P2093 Q56340980-29880C37-DCAF-4222-B49C-D64B15F72D41 @default.
- Q56340980 P2093 Q56340980-318669E1-4008-4251-BF01-154E7BDFE937 @default.
- Q56340980 P2093 Q56340980-3F59DD87-13B2-45E8-8AC1-B897D6E6248B @default.
- Q56340980 P2093 Q56340980-80419774-3685-41F1-945C-8A44F39DAF97 @default.
- Q56340980 P2093 Q56340980-919E19E0-EC4D-455B-99C0-D12D6D30E82C @default.
- Q56340980 P2093 Q56340980-A2FD1D9E-DF2E-473E-AFA3-E725AB874E46 @default.
- Q56340980 P2093 Q56340980-A467DDCF-10CB-4CC7-A9DA-F83EFEAA7141 @default.
- Q56340980 P2093 Q56340980-A73B4523-AE65-4B11-9554-CDBF86900DD6 @default.
- Q56340980 P2093 Q56340980-C13F37AE-AE49-437E-AC2C-E4CCF898F5F9 @default.
- Q56340980 P2860 Q56340980-87C10829-F683-4396-A158-BD162FF5F844 @default.
- Q56340980 P304 Q56340980-0D02AFB0-E774-4921-916A-562BAF9EBB7F @default.
- Q56340980 P31 Q56340980-7E7A8F34-4A99-41BC-A5AE-BCC6BB805B1D @default.
- Q56340980 P356 Q56340980-341955F0-80FC-43A6-869F-BB8F1112175B @default.
- Q56340980 P407 Q56340980-B3E5D669-E077-48AD-80CF-02E9EB923A5F @default.
- Q56340980 P433 Q56340980-F0274457-E4F0-4456-9874-21BAEFDE6559 @default.
- Q56340980 P478 Q56340980-B9E8D794-DEF7-4BA9-A7A2-AA53E9F55737 @default.
- Q56340980 P50 Q56340980-17E1A938-068F-470A-864C-0C27D18F30E8 @default.
- Q56340980 P50 Q56340980-19F3B915-7FE0-471B-917F-7F359205F885 @default.
- Q56340980 P50 Q56340980-65D21567-3875-4861-B416-C5D132B60B93 @default.
- Q56340980 P50 Q56340980-74E7134C-C04E-49FE-BB24-7BA337430238 @default.
- Q56340980 P50 Q56340980-8A90C38D-C12A-4159-B8D3-79A0BD223D36 @default.
- Q56340980 P50 Q56340980-A7EF1C7E-2B0C-4E43-A3AC-76B12E978B54 @default.
- Q56340980 P50 Q56340980-C5FCBFD5-ECD0-4F5A-9050-FE1865F09835 @default.
- Q56340980 P50 Q56340980-E6781103-C5AC-4B50-ACA8-5846C301EDD0 @default.
- Q56340980 P577 Q56340980-999A188E-A256-4685-A384-ED807B68794B @default.
- Q56340980 P698 Q56340980-CD97DD15-37AE-4C95-AC1D-0903BAC603D0 @default.
- Q56340980 P921 Q56340980-C761A9A8-7FB0-4A1E-B325-F6F2AD11C50C @default.
- Q56340980 P356 ACS.JMEDCHEM.8B00610 @default.
- Q56340980 P698 30078314 @default.
- Q56340980 P1433 Q900316 @default.
- Q56340980 P1476 "Tau-Centric Multitarget Approach for Alzheimer's Disease: Development of First-in-Class Dual Glycogen Synthase Kinase 3β and Tau-Aggregation Inhibitors" @default.
- Q56340980 P2093 "Barbara Monti" @default.
- Q56340980 P2093 "Carlos Roca" @default.
- Q56340980 P2093 "Concepción Perez" @default.
- Q56340980 P2093 "Giampaolo Zuccheri" @default.
- Q56340980 P2093 "Giuseppe Legname" @default.
- Q56340980 P2093 "Josefa Zaldivar-Diez" @default.
- Q56340980 P2093 "Loreto Martinez-Gonzalez" @default.
- Q56340980 P2093 "Manuela Bartolini" @default.
- Q56340980 P2093 "Martina Rossi" @default.
- Q56340980 P2093 "Sabrina Castellano" @default.
- Q56340980 P2093 "Sabrina Petralla" @default.
- Q56340980 P2860 Q40314472 @default.
- Q56340980 P304 "7640-7656" @default.
- Q56340980 P31 Q13442814 @default.
- Q56340980 P356 "10.1021/ACS.JMEDCHEM.8B00610" @default.
- Q56340980 P407 Q1860 @default.
- Q56340980 P433 "17" @default.
- Q56340980 P478 "61" @default.
- Q56340980 P50 Q30506374 @default.
- Q56340980 P50 Q38802790 @default.
- Q56340980 P50 Q52087981 @default.
- Q56340980 P50 Q56905412 @default.
- Q56340980 P50 Q57081082 @default.
- Q56340980 P50 Q85836971 @default.
- Q56340980 P50 Q88349090 @default.
- Q56340980 P50 Q88786790 @default.
- Q56340980 P577 "2018-08-24T00:00:00Z" @default.
- Q56340980 P698 "30078314" @default.
- Q56340980 P921 Q11081 @default.